Frank\u00adfurt am Main \u2014 Deut\u00adsche Betei\u00adli\u00adgungs AG (DBAG) is inves\u00adt\u00ading in Hipp Tech\u00adno\u00adlogy Group (\u201cHipp\u201d), a leading deve\u00adlo\u00adp\u00adment and manu\u00adfac\u00adtu\u00adring part\u00adner for medi\u00adcal tech\u00adno\u00adlogy with a focus on implan\u00adto\u00adlogy, surgi\u00adcal instru\u00adments and surgi\u00adcal instru\u00adment systems in the ortho\u00adpae\u00addic and dental indus\u00adtry. DBAG Fund VIII, a fund advi\u00adsed by DBAG, will acquire the majo\u00adrity of the shares repre\u00adsen\u00adted by the Swiss invest\u00adment company Endura AG from the previous owners as part of a manage\u00adment buy-out. <\/p>\n
Simi\u00adlar to the invest\u00adment in MAIT, the tran\u00adsac\u00adtion was agreed via DBAG\u2019s own network ahead of a poten\u00adti\u00adally broad-based struc\u00adtu\u00adred sales process. Foun\u00adder and CEO Markus Hipp will retain a signi\u00adfi\u00adcant stake in the company and will conti\u00adnue to actively shape the next growth phase. The closing of the tran\u00adsac\u00adtion is subject to regu\u00adla\u00adtory appr\u00adovals. The parties have agreed not to disc\u00adlose the purchase price.<\/p>\n
Specia\u00adlist for implan\u00adto\u00adlogy and high-precis\u00adion components The company also has exten\u00adsive exper\u00adtise in the high-precis\u00adion machi\u00adning of deman\u00adding mate\u00adri\u00adals such as tita\u00adnium and special alloys. These skills are also used in other tech\u00adno\u00adlo\u00adgi\u00adcally deman\u00adding indus\u00adtries. For exam\u00adple, the Group manu\u00adfac\u00adtures precis\u00adion and system compon\u00adents for appli\u00adca\u00adti\u00adons in the aero\u00adspace indus\u00adtry, for litho\u00adgra\u00adphy and laser proces\u00adsing systems and for sensor applications. <\/p>\n The Group employs around 350 people at five loca\u00adti\u00adons and has long-stan\u00adding rela\u00adti\u00adonships with leading OEM custo\u00admers worldwide.<\/p>\n Growth through struc\u00adtu\u00adral market trends<\/strong><\/p>\n The invest\u00adment follows DBAG\u2019s stra\u00adtegy of making targe\u00adted invest\u00adments in compa\u00adnies opera\u00adting in struc\u00adtu\u00adrally attrac\u00adtive markets. The market for ortho\u00adpae\u00addic implants bene\u00adfits from long-term growth drivers such as demo\u00adgra\u00adphic change, incre\u00adasing outsour\u00adcing by OEMs and rising regu\u00adla\u00adtory requi\u00adre\u00adments. Hipp is excel\u00adlently posi\u00adtio\u00adned in this envi\u00adron\u00adment. The company has modern, highly auto\u00adma\u00adted produc\u00adtion capa\u00adci\u00adties, a high level of verti\u00adcal inte\u00adgra\u00adtion and exten\u00adsive regu\u00adla\u00adtory exper\u00adtise \u2014 inclu\u00adding with regard to the requi\u00adre\u00adments of the U.S. Food and Drug Admi\u00adnis\u00adtra\u00adtion (FDA) and the Euro\u00adpean Medi\u00adcal Device Regu\u00adla\u00adtion (MDR). <\/p>\n \u201cHipp is a true hidden cham\u00adpion in a resi\u00adli\u00adent market: the company supplies essen\u00adtial products for opera\u00adti\u00adons that are perfor\u00admed thou\u00adsands of times a day around the world,\u201d says Tom Alzin, Spokes\u00adman of the Manage\u00adment Board of Deut\u00adsche Betei\u00adli\u00adgungs AG<\/strong>. He adds: \u201cMarkus Hipp is an excep\u00adtio\u00adnal entre\u00adpre\u00adneur. Toge\u00adther we see considera\u00adble poten\u00adtial to further acce\u00adle\u00adrate the inter\u00adna\u00adtio\u00adnal expan\u00adsion \u2014 espe\u00adci\u00adally in the US as the worl\u00add\u2019s largest medi\u00adcal tech\u00adno\u00adlogy market \u2014 and to further streng\u00adthen Hipp as a prefer\u00adred part\u00adner of global OEMs.\u201d <\/p>\n Conti\u00adnuity and long-term growth strategy With DBAG Fund VIII as the new majo\u00adrity share\u00adhol\u00adder, this growth course is to be consis\u00adt\u00adently contin\u00adued. In addi\u00adtion to expan\u00adding exis\u00adting custo\u00admer rela\u00adti\u00adonships, the focus is on inter\u00adna\u00adtio\u00adnal expan\u00adsion in parti\u00adcu\u00adlar. The company is also exami\u00adning stra\u00adte\u00adgic acqui\u00adsi\u00adti\u00adons in order to further expand its tech\u00adno\u00adlo\u00adgies, exper\u00adtise and market presence. <\/p>\n Markus Hipp, foun\u00adder and CEO of the Hipp Tech\u00adno\u00adlogy Group, says: \u201cFor our custo\u00admers in the medi\u00adcal tech\u00adno\u00adlogy sector, quality, precis\u00adion and relia\u00adbi\u00adlity are the basis for pati\u00adent safety.\u201d He adds: \u201cIn DBAG, we have found a part\u00adner who under\u00adstands the German SME sector very well and at the same time shares our company\u2019s entre\u00adpre\u00adneu\u00adrial values. I parti\u00adcu\u00adlarly appre\u00adciate the prono\u00adun\u00adced under\u00adstan\u00adding of values and the short decis\u00adion-making proces\u00adses. For our employees and our company, the invest\u00adment of DBAG Fund VIII is a stable and future-orien\u00adted solu\u00adtion to further deve\u00adlop the great poten\u00adtial of our group and to drive both strong orga\u00adnic growth and targe\u00adted stra\u00adte\u00adgic acquisitions.\u201d <\/p>\n Deut\u00adsche Betei\u00adli\u00adgungs AG (DBAG)<\/strong>, which has been listed on the stock exch\u00adange since 1985, is one of the most renow\u00adned private equity compa\u00adnies in Germany. As an inves\u00adtor and fund advi\u00adsor, DBAG\u2019s invest\u00adment focus has tradi\u00adtio\u00adnally been on medium-sized compa\u00adnies with a focus on well-posi\u00adtio\u00adned compa\u00adnies with deve\u00adlo\u00adp\u00adment poten\u00adtial, prima\u00adrily in the DACH region. The sector focus is on produ\u00adcers of indus\u00adtrial goods, indus\u00adtrial service provi\u00adders and Indus\u00adtry\u00adTech compa\u00adnies \u2014 i.e. compa\u00adnies whose products enable auto\u00adma\u00adtion, robo\u00adtics and digi\u00adta\u00adliza\u00adtion \u2014 as well as compa\u00adnies from the busi\u00adness services, IT services, soft\u00adware, health\u00adcare, envi\u00adron\u00adment, energy and infra\u00adstruc\u00adture sectors. DBAG has also been active in Italy since 2020 and has had its own office in Milan since 2021. The assets mana\u00adged or advi\u00adsed by the DBAG Group amount to around 2.7 billion euros<\/strong>. ELF Capi\u00adtal comple\u00adments DBAG\u2019s range of flexi\u00adble finan\u00adcing solu\u00adti\u00adons for SMEs with private debt capi\u00adtal. \u2014 www.dbag.de<\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" Frank\u00adfurt am Main \u2014 Deut\u00adsche Betei\u00adli\u00adgungs AG (DBAG) is inves\u00adt\u00ading in Hipp Tech\u00adno\u00adlogy Group (\u201cHipp\u201d), a leading deve\u00adlo\u00adp\u00adment and manu\u00adfac\u00adtu\u00adring part\u00adner for medi\u00adcal tech\u00adno\u00adlogy with a focus on implan\u00adto\u00adlogy, surgi\u00adcal instru\u00adments and surgi\u00adcal instru\u00adment systems in the ortho\u00adpae\u00addic and dental indus\u00adtry. DBAG Fund VIII, a fund advi\u00adsed by DBAG, will acquire the majo\u00adrity of the [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":60030,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-60032","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"\n
\n<\/strong>
\n The Hipp Tech\u00adno\u00adlogy Group is a specia\u00adli\u00adzed deve\u00adlo\u00adp\u00adment and manu\u00adfac\u00adtu\u00adring part\u00adner for the ortho\u00adpae\u00addic and dental indus\u00adtry. The company deve\u00adlops and manu\u00adfac\u00adtures implants, bone proces\u00adsing tools, surgi\u00adcal instru\u00adments and complete system compon\u00adents for robot-assis\u00adted surgi\u00adcal systems for leading medi\u00adcal tech\u00adno\u00adlogy companies.
\nHipp has exten\u00adsive exper\u00adtise in implan\u00adto\u00adlogy and supports its custo\u00admers along the entire value chain \u2014 from deve\u00adlo\u00adp\u00adment and proto\u00adtype produc\u00adtion to series produc\u00adtion, sterile pack\u00ada\u00adging and dock-to-stock solutions. <\/p>\n
\nSince its foun\u00adda\u00adtion in 1993, Hipp has deve\u00adlo\u00adped from a specia\u00adli\u00adzed contract manu\u00adfac\u00adtu\u00adrer into an inter\u00adna\u00adtio\u00adnally active contract manu\u00adfac\u00adtu\u00adring orga\u00adniza\u00adtion and an estab\u00adlished supplier of implants, surgi\u00adcal instru\u00adments and sterile surgi\u00adcal instru\u00adment systems.<\/p>\n